alanylproline has been researched along with valyl-prolyl-proline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, F; Huo, J; Jin, H; Wang, W; Wang, Y; Wang, Z; Zhang, L; Zhang, S; Zhou, L | 1 |
| Aldini, G; De Luca, L; Marconi, C; Pedretti, A; Regazzoni, L; Vistoli, G | 1 |
2 other study(ies) available for alanylproline and valyl-prolyl-proline
| Article | Year |
|---|---|
Angiotensin-I-converting enzyme inhibitory peptides: Chemical feature based pharmacophore generation.
Topics: Algorithms; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Databases, Factual; Humans; Hydrogen Bonding; Hypertension; Male; Models, Chemical; Models, Molecular; Peptides; Peptidyl-Dipeptidase A; Quantitative Structure-Activity Relationship; Software; Solutions; Testis | 2011 |
Fragmental modeling of hPepT2 and analysis of its binding features by docking studies and pharmacophore mapping.
Topics: Binding Sites; Computer Simulation; Drug Design; Humans; Ligands; Models, Molecular; Peptides; Protein Binding; Structural Homology, Protein; Symporters | 2011 |